Skip to main content
. 2021 Feb 19;268(9):3116–3124. doi: 10.1007/s00415-021-10444-6

Fig. 1.

Fig. 1

Serum total α-synuclein (αSyn) in controls, COVID-19 patients with neurological manifestations (COVID-19-NRL), and COVID-19 patients